Skip to main content

Global Vaccines Market to Achieve 6–9% CAGR, Powered by New Vaccines and Demand by 2029

 


The global vaccines market is anticipated to grow at a steady CAGR of around 6-9% over the forecast period, driven by several factors. Key drivers include increased investment in vaccine research and development, growing awareness of immunization benefits, the introduction of new and innovative vaccines targeting previously unmet healthcare needs, and ongoing government support for vaccine programs. However, market growth faces challenges, such as high R&D costs and logistical hurdles, particularly in low-income regions with limited healthcare infrastructure. 

The vaccine market encompasses the research, development, production, and distribution of vaccines, which are biological preparations that stimulate an individual’s immune system to provide immunity against specific diseases. These vaccines are crucial in preventing infectious diseases and reducing mortality rates worldwide. The market includes various vaccines targeting viral, bacterial, and parasitic infections, administered through government immunization programs, private healthcare providers, and non-profit organizations. In addition, the market is influenced by increasing awareness about immunization benefits and the ongoing expansion of vaccination campaigns globally.

Click here to get our sample PDF report for Medical Devices market:
https://meditechinsights.com/global-vaccines-market/request-sample/

Rising Global Demand: Addressing the Surge in Infectious Diseases

The increasing global incidence of infectious diseases is a primary factor driving growth in the vaccine market. Rising concerns about contagious diseases such as COVID-19, seasonal influenza, hepatitis, and human papillomavirus (HPV) have underscored the need for effective, readily available vaccines. Health organizations and governments are increasingly prioritizing vaccination efforts to prevent disease outbreaks, lower healthcare expenses associated with treating infectious diseases, and improve public health outcomes. In addition to reducing individual health risks, vaccines contribute to community-wide protection, encouraging higher immunization rates across diverse population groups. The awareness generated by recurrent pandemics and local disease outbreaks further bolsters public demand for vaccines, positioning immunization as a critical component of preventive healthcare.

Transformative Innovation: Advancements in mRNA Vaccine Technology

Advancements in mRNA vaccine technology represent a pivotal trend in the vaccine market, with the potential to reshape the sector profoundly. mRNA technology allows rapid vaccine development by using genetic information to direct the body’s cells to produce an immune response to specific pathogens. This approach has proven highly effective, as demonstrated by the swift development and deployment of COVID-19 vaccines, which achieved high efficacy in a record production time. Research into mRNA is now extending beyond COVID-19, with applications under exploration for other infectious diseases and even therapeutic areas such as oncology. These advancements boost vaccine accessibility and speed, while also enabling the development of precision-targeted vaccines, fueling ongoing innovation in the market.

Competitive Landscape Analysis

The global vaccines market is marked by the presence of established and emerging market players such as Merck & Co. Inc.; Pfizer Inc.; Moderna Inc.; Serum Institute of India Pvt. Ltd.; Seqirus; Sanofi; GSK Plc.; Sinovac; BioNTech SE; AstraZeneca; and Emergent among others. Leading companies are focusing on key strategies such as product innovation and development, forming strategic partnerships and collaborations, and expanding their geographic presence to strengthen their market position.

Get PDF Report for Competitive Analysis:
https://meditechinsights.com/global-vaccines-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides size of the vaccine market at the regional- and country-level from 2022 to 2029. The report further segments the market on the basis of vaccine type, route of administration, disease type, age and distribution channel.

  • Market Size & Forecast (2022-2029), By Vaccine Type, USD Million
    • Recombinant Vaccines
    • Conjugate Vaccines
    • Inactivated
    • Live Attenuated
    • Viral Vector Vaccines
    • mRNA Vaccines
    • Others
  • Market Size & Forecast (2022-2029), By Route of Administration, USD Million
    • Oral
    • Parenteral
    • Nasal
  • Market Size & Forecast (2022-2029), By Disease Type, USD Million
    • Viral Diseases
      • Hepatitis
      • Influenza
      • HPV
      • MMR
      • Rotavirus
      • Herpes Zoster
      • Covid-19
      • Others
    • Bacterial Vaccines
      • Meningococcal Diseases
      • Pneumococcal diseases
      • DPT
      • Others
    • Cancer Vaccines
    • Allergy Vaccines
  • Market Size & Forecast (2022-2029), By Age, USD Million
    • Paediatric
    • Adult
  • Market Size & Forecast (2022-2029), By Distribution Channel, USD Million
    • Hospital & Retail Pharmacies
    • Government Suppliers
    • Others
  • Market Size & Forecast (2022-2029), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more